White label ELPA - ClinicalTrials.eu

Study on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Active Psoriatic Arthritis

Not recruiting

3 1 1
Investigated diseases:
- Psoriatic arthropathy
Investigated drugs:
- Bimekizumab
+2
Study on the Effectiveness and Safety of Allergenic Extract of Olea Europaea Pollen for Patients with Moderate-to-Severe Olive Pollen Allergy

Not recruiting

4 1 1
Investigated diseases:
- Seasonal allergy
- Conjunctivitis allergic
Investigated drugs:
Study on Obinutuzumab, Chlorambucil, and Acalabrutinib for Patients with Untreated Chronic Lymphocytic Leukemia

Not recruiting

3 1 1 1
Investigated diseases:
- Chronic lymphocytic leukaemia
Investigated drugs:
+3
Study on Inclisiran and Statin Therapy for Patients with Non-obstructive Coronary Artery Disease to Assess Atherosclerotic Plaque Progression

Not recruiting

3 1 1
Investigated diseases:
- Coronary artery disease
Investigated drugs:
Study on the Long-Term Safety of Seladelpar for Patients with Primary Biliary Cholangitis

Not recruiting

3 1 1
Investigated diseases:
- Primary biliary cholangitis
Investigated drugs:
- Seladelpar
+6
Study of Datopotamab Deruxtecan for Patients with Advanced or Metastatic Non-small Cell Lung Cancer with Specific Genetic Changes

Not recruiting

2 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
- Datopotamab Deruxtecan
Study on the Safety and Effectiveness of Crinecerfont for Adults with Classic Congenital Adrenal Hyperplasia

Not recruiting

3 1
Investigated diseases:
- Adrenogenital syndrome
Investigated drugs:
- Crinecerfont
+6
Study of ianalumab versus placebo in adults with warm autoimmune hemolytic anemia who failed previous treatment

Not recruiting

3 1 1
Investigated diseases:
- Warm autoimmune haemolytic anaemia
Investigated drugs:
Study of Ifinatamab Deruxtecan for Patients with Previously Treated Extensive-Stage Small Cell Lung Cancer

Not recruiting

2 1 1
Investigated diseases:
- Small cell lung cancer extensive stage
Investigated drugs:
- Ifinatamab Deruxtecan
Study of Durbactagene Autoleucel and Drug Combination for Adults with Relapsed and Refractory Multiple Myeloma

Not recruiting

2 1 1 1
Investigated diseases:
- Plasma cell myeloma
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies